Skip to main content
National News Desk
health

Centre proposes separate licensing framework for wholesale trade of bulk drugs

Hindustan Times IndiaBy Hindustan Times India
19 Nov 2026
Original: English
AI Synopsis & Key Briefing

Centre proposes separate licensing framework for wholesale trade of bulk drugs

Key Highlights & Official Takeaways
  • ✓Centre proposes separate licensing framework for wholesale trade of bulk drugs
  • ✓Primary Authority: Official communique verified from Hindustan Times India.
  • ✓Civic Domain: Categorized under health public notices.
Comprehensive News & Policy Report

New Delhi, The Ministry of Health and Family Welfare has proposed a separate licensing framework for the wholesale trade of bulk drugs, including active and inactive bulk substances, to strengthen regulatory oversight and accountability in the pharmaceutical supply chain.

Centre proposes separate licensing framework for wholesale trade of bulk drugsThe proposed amendments to the Drugs Rules, 1945, seek to introduce separate application and licence forms for the wholesale of bulk drugs, distinct from the existing licensing provisions for formulations.

At present, a common licence covers the wholesale of both formulations and bulk drugs. The proposed amendment seeks to establish a dedicated licensing framework for bulk drugs, enabling more focused regulatory oversight of their wholesale trade and greater accountability in the pharmaceutical supply chain, the ministry said in a statement.

The proposal was agreed upon by the Drugs Consultative Committee at its 67th meeting on November 17, 2025, and by the Drugs Technical Advisory Board at its 93rd meeting on February 16, 2026. Under the proposed framework, the licence will capture the categories of bulk drugs handled by wholesalers, including drugs covered under the Narcotic Drugs and Psychotropic Substances Act, 1985.

The sale of bulk drugs will be carried out under the supervision of a competent person, thereby strengthening accountability in their distribution and handling, the ministry said. Upon implementation, the proposed amendment will give better control over the wholesale of bulk drugs and strengthen enforcement control in relation to antimicrobial resistance and the movement of NDPS drugs, it added.

To facilitate the transition to the revised licensing requirements, the existing licensees will be provided adequate time to comply with the new provisions, the ministry said. The requirements will become applicable to them only upon expiry of their current retention period or 12 months after the final publication of the amendment, whichever is later, the statement said.

The ministry has invited objections and suggestions from stakeholders and the public within 30 days from the date on which copies of the gazette containing the draft rules are made available to them. This article was generated from an automated news agency feed without modifications to text.

Actionable Steps for Aspirants & Citizens
  • •Aspirants and citizens are advised to monitor official notices and circulars issued by Hindustan Times India.
  • •Verify all prescribed eligibility criteria, cutoff dates, and authenticated document requirements prior to formal submissions.
  • •Track connected examination timetables, vacancy advisories, and administrative gazettes on SuchnaSetu.
Official Notice Specification
Issuing AuthorityHindustan Times India
Topic CategoryHEALTH
JurisdictionAll India / National
Publication Date19 November 2026
Connected Government Jobs & Upcoming Exams
Active on SuchnaSetu
Official Source Attribution: Hindustan Times India
View Publisher Source Link

SuchnaSetu provides verified civic and public policy reports based on official notices. Primary publication and copyright remain with the respective government authority or publisher.